Intersect ENT Total Liabilities

Intersect ENT (XENT) currently reports a total liabilities of $220M as of March 2022. That compares with $160M in the prior-year period — up 40.0% year over year. Use the charts on this page to explore Intersect ENT's total liabilities history and peer comparisons.

Intersect ENT's total liabilities increased from $160M to $220M — a 40.0% year-over-year increase (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intersect ENT reported $220M in total liabilities as of March 2022. That compares with $160M in the prior-year period — up 40.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $220M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Intersect ENT, and consider following XENT for alerts when major investors trade the stock.

Intersect ENT is classified in the Healthcare sector. On total liabilities, it currently shows $220M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing XENT with unrelated industries.